Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$279K Sell
794
-75
-9% -$26.7K 0.11% 117
2025
Q4
$284K Hold
869
0.12% 118
2025
Q3
$245K Hold
869
0.1% 127
2025
Q2
$243K Buy
869
+30
+4% +$8.5K 0.11% 123
2025
Q1
$261K Buy
839
+30
+4% +$8.86K 0.12% 117
2024
Q4
$211K Hold
809
0.08% 124
2024
Q3
$261K Sell
809
-35
-4% -$11.4K 0.11% 109
2024
Q2
$264K Hold
844
0.12% 105
2024
Q1
$240K Hold
844
0.11% 112
2023
Q4
$243K Sell
844
-80
-9% -$21.8K 0.12% 104
2023
Q3
$248K Hold
924
0.13% 103
2023
Q2
$205K Sell
924
-118
-11% -$27.4K 0.1% 114
2023
Q1
$252K Hold
1,042
0.12% 101
2022
Q4
$274K Hold
1,042
0.13% 99
2022
Q3
$234K Hold
1,042
0.12% 100
2022
Q2
$253K Hold
1,042
0.12% 97
2022
Q1
$251K Hold
1,042
0.11% 103
2021
Q4
$234K Hold
1,042
0.1% 110
2021
Q3
$221K Hold
1,042
0.1% 106
2021
Q2
$253K Buy
1,042
+91
+10% +$22.4K 0.11% 104
2021
Q1
$236K Hold
951
0.11% 105
2020
Q4
$218K Hold
951
0.11% 100
2020
Q3
$241K Hold
951
0.13% 91
2020
Q2
$224K Buy
+951
New +$217K 0.13% 93
2020
Q1
Sell
-951
Closed -$229K 100
2019
Q4
$229K Buy
+951
New +$210K 0.11% 102

Other funds holding AMGN

Schulhoff & Co's AMGN Position: Q1 2026 in Review

Schulhoff & Co reduced its Amgen (AMGN) stake by 8.6% in Q1 2026, selling an estimated $26.7K and leaving 794 shares worth $279K. The position accounts for 0.11% of the portfolio, ranked #117.

Schulhoff & Co first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $284K in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Schulhoff & Co held 794 shares of Amgen worth $279K as of Q1 2026.
  • Schulhoff & Co sold 75 Amgen shares in Q1 2026, an estimated $26.7K.
  • Amgen made up 0.11% of Schulhoff & Co's portfolio in Q1 2026, its #117 holding.
  • Schulhoff & Co first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
  • Schulhoff & Co's Amgen position peaked at $284K in Q4 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Schulhoff & Co's 13F filing for Q1 2026, filed 11 May 2026.